An Indian SME working on developing agentic AI workflow systems to accelerate drug discovery and development is seeking potential European partners for technology, R&D, academic and business collaborations
The Indian Company, having its proprietary software applies cutting edge technologies like AI, Deep Learning Networks and Machine Learning algorithms using data driven approaches to re-design the conventional drug design practices involving small molecules, peptides and proteins. With the client’s robust discovery and product pipeline, research can be accelerated using latest technology and data driven approaches.